Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
CHD5	26038	broad.mit.edu	37	1	6189059	6189059	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr1:6189059G>A	ENST00000262450.3	-	23	3557	c.3458C>T	c.(3457-3459)tCg>tTg	p.S1153L	CHD5_ENST00000378021.1_Missense_Mutation_p.S10L	NM_015557.2	NP_056372.1	Q8TDI0	CHD5_HUMAN	chromodomain helicase DNA binding protein 5	1153	Helicase C-terminal.	NA			chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	ATP binding|ATP-dependent helicase activity|DNA binding|zinc ion binding	p.S1153L(1)		breast(3)|central_nervous_system(3)|liver(1)|lung(1)|ovary(4)|pancreas(1)|skin(1)|upper_aerodigestive_tract(2)	16	Ovarian(185;0.0634)	all_cancers(23;5.36e-32)|all_epithelial(116;2.32e-17)|all_neural(13;3.68e-06)|all_lung(118;3.94e-06)|all_hematologic(16;2.39e-05)|Lung NSC(185;5.33e-05)|Acute lymphoblastic leukemia(12;0.000372)|Glioma(11;0.00127)|Renal(390;0.00188)|Colorectal(325;0.00342)|Breast(487;0.00373)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.15)		Epithelial(90;3.08e-37)|GBM - Glioblastoma multiforme(13;1.36e-31)|OV - Ovarian serous cystadenocarcinoma(86;7.7e-19)|Colorectal(212;9.97e-08)|COAD - Colon adenocarcinoma(227;1.07e-05)|Kidney(185;6.16e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.00109)|BRCA - Breast invasive adenocarcinoma(365;0.0012)|STAD - Stomach adenocarcinoma(132;0.00346)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.193)		CTCCTCCACCGAGGCCCGAGT	0.662		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	central_nervous_system(1)											58	54	56			NA	NA	1		NA											NA				6189059		2203	4300	6503	SO:0001583	missense			ENSG00000116254	HGNC:16816	NM_015557	Approved	uc001amb.2	NA	O75032|Q5TG89|Q7LGH2|Q9UFR9	ENST00000262450.3	37	CCDS57.1	.	.	.	.	.	.	.	.	.	.	G	33	5.264668	0.95399	.	.	ENSG00000116254	ENST00000262450;ENST00000378006;ENST00000378021;ENST00000536802;ENST00000538279;ENST00000377999	T;T	0.79554	-1.28;1.44	4.62	4.62	0.57501	Helicase, C-terminal (1);	0.000000	0.64402	D	0.000002	D	0.91412	0.7290	M	0.89904	3.07	0.53688	D	0.99997	D;D	0.89917	0.997;1.0	D;D	0.73708	0.968;0.981	D	0.93470	0.6818	10	0.87932	D	0	-10.2741	17.823	0.88656	0.0:0.0:1.0:0.0	.	1153;10	Q8TDI0;Q5TG85	CHD5_HUMAN;.	L	1153;669;10;561;561;10	ENSP00000262450:S1153L;ENSP00000367260:S10L	ENSP00000262450:S1153L	S	-	2	0	CHD5	6111646	1	0.71417	0.916	0.36221	0.975	0.68041	6.425	0.7337	2.268	0.75426	0.561	0.74099	TCG	CHD5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000002823.2	76.932343	KEEP		-	85.463592	0.237037	32	103	---	---	---	---	1	1	503	1318	2	1585	41	119	0	89	15	TP
PRPF38A	84950	broad.mit.edu	37	1	52880488	52880488	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr1:52880488C>G	ENST00000257181.9	+	8	990	c.804C>G	c.(802-804)agC>agG	p.S268R	PRPF38A_ENST00000474048.1_3'UTR	NM_032864.3	NP_116253.2	Q8NAV1	PR38A_HUMAN	pre-mRNA processing factor 38A	268	Arg-rich.	NA			mRNA processing|RNA splicing	spliceosomal complex				cervix(2)|kidney(1)|large_intestine(2)|liver(1)|lung(2)|stomach(1)	9						GTCACCGCAGCAGGTCCCGAG	0.527		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													65	68	67			NA	NA	1		NA											NA				52880488		2203	4300	6503	SO:0001583	missense			ENSG00000134748	HGNC:25930	NM_032864	Approved	uc001ctw.4	NA	Q96JW1|Q9BVZ8	ENST00000257181.9	37	CCDS567.1	.	.	.	.	.	.	.	.	.	.	C	13.26	2.182909	0.38511	.	.	ENSG00000134748	ENST00000257181	T	0.46063	0.88	5.71	3.78	0.43462	Pre-mRNA-splicing factor 38, C-terminal (1);	0.073982	0.85682	D	0.000000	T	0.44329	0.1288	L	0.31664	0.95	0.80722	D	1	D	0.67145	0.996	D	0.75020	0.985	T	0.28744	-1.0034	10	0.14252	T	0.57	-19.9388	7.8953	0.29702	0.0:0.6676:0.0:0.3324	.	268	Q8NAV1	PR38A_HUMAN	R	268	ENSP00000257181:S268R	ENSP00000257181:S268R	S	+	3	2	PRPF38A	52653076	1	0.71417	1	0.80357	0.997	0.91878	1.756	0.3839	0.699	0.31761	0.65	0.86243	AGC	PRPF38A-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000022459.2	95.739459	KEEP		+	113.946141	0.186869	37	161	---	---	---	---	1	1	304	828	1	930	47	199	0	198	14	TP
SPTA1	6708	broad.mit.edu	37	1	158618368	158618368	+	Silent	SNP	C	C	G			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr1:158618368C>G	ENST00000368148.3	-	26	3825	c.3645G>C	c.(3643-3645)ctG>ctC	p.L1215L	SPTA1_ENST00000368147.3_Silent_p.L1215L	NM_003126.2	NP_003117.2	P02549	SPTA1_HUMAN	spectrin, alpha, erythrocytic 1 (elliptocytosis 2)	1215		NA			actin filament capping|actin filament organization|axon guidance|regulation of cell shape	cytosol|intrinsic to internal side of plasma membrane|spectrin|spectrin-associated cytoskeleton	actin filament binding|calcium ion binding|structural constituent of cytoskeleton			NS(3)|breast(7)|cervix(1)|endometrium(22)|kidney(9)|large_intestine(29)|liver(2)|lung(183)|ovary(5)|prostate(18)|skin(11)|soft_tissue(1)|stomach(1)|upper_aerodigestive_tract(9)|urinary_tract(6)	307	all_hematologic(112;0.0378)					GAACACTGAACAGATCTGAGC	0.507		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													122	121	121			NA	NA	1		NA											NA				158618368		1959	4147	6106	SO:0001819	synonymous_variant			ENSG00000163554	HGNC:11272	NM_003126	Approved	uc001fst.1	NA	Q15514|Q5VYL1|Q5VYL2|Q6LDY5	ENST00000368148.3	37	CCDS41423.1												NA	NA	NA								NA	NA	NA																																													NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		SPTA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051851.2	83.30056	KEEP		-	108.772933	0.155556	35	190	---	---	---	---	1	1	278	988	0	1393	39	212	0	212	2	TP
SPTA1	6708	broad.mit.edu	37	1	158627401	158627401	+	Nonsense_Mutation	SNP	G	G	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr1:158627401G>A	ENST00000368148.3	-	19	2851	c.2671C>T	c.(2671-2673)Cga>Tga	p.R891*	SPTA1_ENST00000368147.3_Nonsense_Mutation_p.R891*	NM_003126.2	NP_003117.2	P02549	SPTA1_HUMAN	spectrin, alpha, erythrocytic 1 (elliptocytosis 2)	891		NA			actin filament capping|actin filament organization|axon guidance|regulation of cell shape	cytosol|intrinsic to internal side of plasma membrane|spectrin|spectrin-associated cytoskeleton	actin filament binding|calcium ion binding|structural constituent of cytoskeleton	p.R891*(1)		NS(3)|breast(7)|cervix(1)|endometrium(22)|kidney(9)|large_intestine(29)|liver(2)|lung(183)|ovary(5)|prostate(18)|skin(11)|soft_tissue(1)|stomach(1)|upper_aerodigestive_tract(9)|urinary_tract(6)	307	all_hematologic(112;0.0378)					TCATTTTGTCGCCTAGCAGCT	0.463		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Nonsense(1)	endometrium(1)											175	172	173			NA	NA	1		NA											NA				158627401		2011	4191	6202	SO:0001587	stop_gained			ENSG00000163554	HGNC:11272	NM_003126	Approved	uc001fst.1	NA	Q15514|Q5VYL1|Q5VYL2|Q6LDY5	ENST00000368148.3	37	CCDS41423.1	.	.	.	.	.	.	.	.	.	.	G	37	6.627707	0.97718	.	.	ENSG00000163554	ENST00000368148;ENST00000368147	.	.	.	4.67	2.72	0.32119	.	0.000000	0.29609	N	0.011661	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	12.3699	0.55250	0.0:0.0:0.6925:0.3075	.	.	.	.	X	891	.	ENSP00000357129:R891X	R	-	1	2	SPTA1	156894025	1	0.71417	0.017	0.16124	0.037	0.1314	2.194	0.42668	0.634	0.30469	0.655	0.94253	CGA	SPTA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051851.2	131.827562	KEEP		-	154.813887	0.212625	64	237	---	---	---	---	1	1	285	881	0	929	73	296	0	345	2	TP
SLC30A3	7781	broad.mit.edu	37	2	27481034	27481034	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr2:27481034C>T	ENST00000233535.4	-	3	771	c.419G>A	c.(418-420)cGt>cAt	p.R140H	SLC30A3_ENST00000447008.2_Missense_Mutation_p.R135H	NM_003459.4	NP_003450.2	Q99726	ZNT3_HUMAN	solute carrier family 30 (zinc transporter), member 3	140		NA			regulation of sequestering of zinc ion	cell junction|integral to plasma membrane|late endosome|membrane fraction|synaptic vesicle membrane	zinc transporting ATPase activity			NS(1)|breast(1)|cervix(1)|endometrium(2)|large_intestine(3)|lung(11)|pancreas(1)	20	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)					CTTACCTGAACGGTGCCAGCC	0.642		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													70	76	74			NA	NA	2		NA											NA				27481034		2203	4300	6503	SO:0001583	missense			ENSG00000115194	HGNC:11014		Approved	uc002rjj.3	NA	Q8TC03	ENST00000233535.4	37	CCDS1743.1	.	.	.	.	.	.	.	.	.	.	C	34	5.370315	0.959	.	.	ENSG00000115194	ENST00000233535;ENST00000447008;ENST00000432351;ENST00000426924;ENST00000424577;ENST00000450118;ENST00000426569	T;T;T;T;T;T;T	0.73789	-0.78;-0.78;-0.78;-0.78;-0.78;-0.78;-0.78	5.61	5.61	0.85477	.	0.000000	0.85682	D	0.000000	D	0.91696	0.7375	H	0.98199	4.17	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.91635	0.998;0.999	D	0.94223	0.7469	10	0.87932	D	0	-29.3886	17.5007	0.87731	0.0:1.0:0.0:0.0	.	135;140	F5H3B7;Q99726	.;ZNT3_HUMAN	H	140;135;91;127;118;91;91	ENSP00000233535:R140H;ENSP00000415226:R135H;ENSP00000414320:R91H;ENSP00000393545:R127H;ENSP00000403959:R118H;ENSP00000403912:R91H;ENSP00000392673:R91H	ENSP00000233535:R140H	R	-	2	0	SLC30A3	27334538	1	0.71417	1	0.80357	0.984	0.73092	7.796	0.85898	2.815	0.96918	0.561	0.74099	CGT	SLC30A3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250189.2	83.196702	KEEP		-	106.003107	0.180672	43	195	---	---	---	---	1	1	285	892	2	1099	51	232	0	160	38	TP
PSD4	23550	broad.mit.edu	37	2	113942578	113942578	+	Silent	SNP	C	C	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr2:113942578C>T	ENST00000245796.6	+	3	1296	c.1101C>T	c.(1099-1101)gaC>gaT	p.D367D	PSD4_ENST00000441564.2_Silent_p.D367D	NM_012455.2	NP_036587.2	Q8NDX1	PSD4_HUMAN	pleckstrin and Sec7 domain containing 4	367		NA			regulation of ARF protein signal transduction	cytoplasm|plasma membrane	ARF guanyl-nucleotide exchange factor activity			cervix(1)|endometrium(2)|large_intestine(4)|lung(13)|ovary(4)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	29						cgtgtgtggacgaagcattga	0.547		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													276	249	258			NA	NA	2		NA											NA				113942578		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000125637	HGNC:19096	NM_012455	Approved	uc002tjc.3	NA	A6NEG7|A8K1Y0|O95621|Q4ZG34|Q6GPH8|Q8IYP4	ENST00000245796.6	37	CCDS33276.1												NA	NA	NA								NA	NA	NA																																													NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		PSD4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000330789.1	198.031337	KEEP		+	248.666381	0.182836	98	438	---	---	---	---	1	1	317	1010	0	1206	108	468	0	494	2	TP
SEMA3F	6405	broad.mit.edu	37	3	50211752	50211752	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr3:50211752G>T	ENST00000002829.3	+	5	909	c.425G>T	c.(424-426)tGc>tTc	p.C142F	SEMA3F_ENST00000413852.1_Missense_Mutation_p.C74F|SEMA3F_ENST00000434342.1_Missense_Mutation_p.C142F|MIR566_ENST00000385187.1_RNA	NM_004186.3	NP_004177.3	Q13275	SEM3F_HUMAN	sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F	142	Sema.	NA			axon guidance	extracellular space|membrane	chemorepellent activity|receptor activity			central_nervous_system(1)|kidney(1)|large_intestine(2)|lung(9)|ovary(1)|prostate(1)|skin(2)	17				BRCA - Breast invasive adenocarcinoma(193;0.00013)|KIRC - Kidney renal clear cell carcinoma(197;0.00599)|Kidney(197;0.00688)		AACCCCATGTGCACCTATGTG	0.662		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													78	77	77			NA	NA	3		NA											NA				50211752		2203	4300	6503	SO:0001583	missense			ENSG00000001617	HGNC:10728	NM_004186	Approved	uc003cyj.3	NA	Q13274|Q13372|Q15704|Q6GTR4	ENST00000002829.3	37	CCDS2811.1	.	.	.	.	.	.	.	.	.	.	G	20.9	4.05912	0.76074	.	.	ENSG00000001617	ENST00000414301;ENST00000450338;ENST00000413852;ENST00000002829;ENST00000434342;ENST00000420831	T;T;T;T;T;T	0.43294	0.95;0.95;0.95;0.95;0.95;0.95	5.23	5.23	0.7285	WD40/YVTN repeat-like-containing domain (1);Semaphorin/CD100 antigen (4);	0.247728	0.56097	D	0.000031	T	0.76800	0.4038	H	0.97340	3.985	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.97110	1.0;1.0	D	0.85078	0.0944	10	0.87932	D	0	.	15.4406	0.75178	0.0:0.1393:0.8607:0.0	.	142;142	C9JQ85;Q13275	.;SEM3F_HUMAN	F	142;142;74;142;142;106	ENSP00000392588:C142F;ENSP00000398399:C142F;ENSP00000388931:C74F;ENSP00000002829:C142F;ENSP00000409859:C142F;ENSP00000416356:C106F	ENSP00000002829:C142F	C	+	2	0	SEMA3F	50186756	1	0.71417	1	0.80357	0.96	0.62799	9.566	0.98157	2.596	0.87737	0.561	0.74099	TGC	SEMA3F-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000345929.1	82.651187	KEEP		+	108.202554	0.176923	46	214	---	---	---	---	1	1	226	677	0	908	56	240	0	182	2	TP
STAB1	23166	broad.mit.edu	37	3	52551965	52551965	+	Silent	SNP	C	C	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr3:52551965C>T	ENST00000321725.6	+	45	4783	c.4707C>T	c.(4705-4707)tgC>tgT	p.C1569C		NM_015136.2	NP_055951.2	Q9NY15	STAB1_HUMAN	stabilin 1	1569	EGF-like 13.	NA			cell adhesion|cell-cell signaling|defense response to bacterium|inflammatory response|negative regulation of angiogenesis|receptor-mediated endocytosis	integral to plasma membrane	bacterial cell surface binding|hyaluronic acid binding|low-density lipoprotein receptor activity|protein disulfide oxidoreductase activity|scavenger receptor activity			breast(4)|central_nervous_system(3)|endometrium(7)|kidney(2)|large_intestine(13)|liver(1)|lung(27)|ovary(1)|pancreas(1)|prostate(4)|skin(6)|upper_aerodigestive_tract(4)|urinary_tract(3)	76				BRCA - Breast invasive adenocarcinoma(193;1.73e-05)|Kidney(197;0.00182)|KIRC - Kidney renal clear cell carcinoma(197;0.00205)|OV - Ovarian serous cystadenocarcinoma(275;0.0482)		CATGTACCTGCGACACAGCCC	0.602		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								C		0,4406		0,0,2203	67	64	65		4707	-4.3	0.5	3		65	1,8599		0,1,4299	no	coding-synonymous	STAB1	NM_015136.2		0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077		1569/2571	52551965	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000010327	HGNC:18628	NM_015136	Approved	uc003dej.3	NA	A7E297|Q8IUH0|Q8IUH1|Q93072	ENST00000321725.6	37	CCDS33768.1												NA	NA	NA								NA	NA	NA																																													NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		STAB1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000351380.2	59.724077	KEEP		+	73.945427	0.192547	31	130	---	---	---	---	1	1	477	1462	2	1648	31	136	0	103	9	TP
STXBP5L	9515	broad.mit.edu	37	3	120976020	120976020	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr3:120976020C>T	ENST00000273666.6	+	17	1943	c.1672C>T	c.(1672-1674)Cga>Tga	p.R558*	STXBP5L_ENST00000492541.1_Nonsense_Mutation_p.R558*|STXBP5L_ENST00000471454.1_Nonsense_Mutation_p.R558*|STXBP5L_ENST00000472879.1_Nonsense_Mutation_p.R558*|STXBP5L_ENST00000497029.1_Nonsense_Mutation_p.R558*	NM_014980.2	NP_055795.1	Q9Y2K9	STB5L_HUMAN	syntaxin binding protein 5-like	558		NA			exocytosis|protein transport	cytoplasm|integral to membrane|plasma membrane				NS(1)|breast(3)|endometrium(3)|kidney(3)|large_intestine(12)|lung(28)|ovary(7)|prostate(3)|skin(6)|upper_aerodigestive_tract(1)|urinary_tract(1)	68				GBM - Glioblastoma multiforme(114;0.0694)		ATTAGAGGTACGACTTCAGTA	0.318		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													95	92	93			NA	NA	3		NA											NA				120976020		1820	4077	5897	SO:0001587	stop_gained			ENSG00000145087	HGNC:30757		Approved	uc003eec.4	NA	Q4G1B4|Q6PIC3	ENST00000273666.6	37	CCDS43137.1	.	.	.	.	.	.	.	.	.	.	C	38	7.012818	0.98002	.	.	ENSG00000145087	ENST00000273666;ENST00000471454;ENST00000472879;ENST00000497029;ENST00000492541;ENST00000471262	.	.	.	5.49	5.49	0.81192	.	0.133960	0.52532	D	0.000072	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.07325	T	0.83	-13.9385	19.7341	0.96195	0.0:1.0:0.0:0.0	.	.	.	.	X	558	.	ENSP00000273666:R558X	R	+	1	2	STXBP5L	122458710	1	0.71417	1	0.80357	0.997	0.91878	6.64	0.74319	2.732	0.93576	0.585	0.79938	CGA	STXBP5L-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000355256.3	18.567464	KEEP		+	38.726581	0.119718	17	125	---	---	---	---	1	1	64	346	0	376	21	138	0	225	2	TP
PIK3CA	5290	broad.mit.edu	37	3	178936091	178936091	+	Missense_Mutation	SNP	G	G	A	rs104886003		GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr3:178936091G>A	ENST00000263967.3	+	10	1790	c.1633G>A	c.(1633-1635)Gag>Aag	p.E545K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	545	PI3K helical.	NA	E -> A (in cancer).|E -> G (in KERSEB).|E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation; enhances invadopodia-mediated extracellular matrix degradation and invasion in breast cancer cells).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E545K(881)|p.E545Q(18)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TGAAATCACTGAGCAGGAGAA	0.353	E545K(BC3C_URINARY_TRACT)|E545K(BFTC909_KIDNEY)|E545K(DLD1_LARGE_INTESTINE)|E545K(ESS1_ENDOMETRIUM)|E545K(HCC202_BREAST)|E545K(HCT15_LARGE_INTESTINE)|E545K(HSC4_UPPER_AERODIGESTIVE_TRACT)|E545K(HT1197_URINARY_TRACT)|E545K(HUH28_BILIARY_TRACT)|E545K(KYSE510_OESOPHAGUS)|E545K(L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|E545K(MCF7_BREAST)|E545K(MDAMB361_BREAST)|E545K(MKN1_STOMACH)|E545K(NCIH460_LUNG)|E545K(NCIH508_LARGE_INTESTINE)|E545K(NCIH596_LUNG)|E545K(RERFLCSQ1_LUNG)|E545K(TCCSUP_URINARY_TRACT)|E545K(TE5_OESOPHAGUS)	57	Mis		"""colorectal, gastric, gliobastoma, breast"""		NA			HNSCC(19;0.045)|TSP Lung(28;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""	NA	"""E, O"""	899	Substitution - Missense(899)	breast(308)|large_intestine(286)|urinary_tract(97)|lung(44)|endometrium(37)|ovary(25)|stomach(17)|upper_aerodigestive_tract(16)|skin(14)|central_nervous_system(13)|cervix(13)|thyroid(7)|oesophagus(7)|penis(4)|kidney(3)|soft_tissue(2)|pancreas(2)|haematopoietic_and_lymphoid_tissue(1)|biliary_tract(1)|NS(1)|pituitary(1)											61	60	60			NA	NA	3		NA											NA				178936091		1813	4072	5885	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	36	5.703347	0.96812	.	.	ENSG00000121879	ENST00000263967	T	0.63255	-0.03	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.73822	0.3636	L	0.51914	1.62	0.80722	D	1	D	0.62365	0.991	D	0.62955	0.909	T	0.68872	-0.5294	10	0.32370	T	0.25	-25.7963	20.0024	0.97423	0.0:0.0:1.0:0.0	.	545	P42336	PK3CA_HUMAN	K	545	ENSP00000263967:E545K	ENSP00000263967:E545K	E	+	1	0	PIK3CA	180418785	1	0.71417	1	0.80357	0.951	0.60555	9.476	0.97823	2.722	0.93159	0.467	0.42956	GAG	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	16.307633	KEEP		+	18.262033	0.233333	7	23	---	---	---	---	1	1	182	759	0	758	7	26	0	91	2	TP
PRDM9	56979	broad.mit.edu	37	5	23527680	23527680	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr5:23527680G>T	ENST00000296682.3	+	11	2665	c.2483G>T	c.(2482-2484)gGg>gTg	p.G828V		NM_020227.2	NP_064612.2	Q9NQV7	PRDM9_HUMAN	PR domain containing 9	828		NA			meiosis|regulation of transcription, DNA-dependent|transcription, DNA-dependent	chromosome|nucleoplasm	histone-lysine N-methyltransferase activity|nucleic acid binding|zinc ion binding			NS(1)|breast(1)|central_nervous_system(3)|endometrium(15)|haematopoietic_and_lymphoid_tissue(3)|kidney(2)|large_intestine(27)|lung(87)|ovary(6)|pancreas(2)|prostate(4)|skin(10)|upper_aerodigestive_tract(11)	172						ACACACACAGGGGAGAAGCCC	0.582		NA					NA			HNSCC(3;0.000094)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													42	55	50			NA	NA	5		NA											NA				23527680		2155	4276	6431	SO:0001583	missense			ENSG00000164256	HGNC:13994	NM_020227	Approved	uc003jgo.3	NA	B4DX22|Q27Q50	ENST00000296682.3	37	CCDS43307.1	.	.	.	.	.	.	.	.	.	.	G	10.41	1.341243	0.24339	.	.	ENSG00000164256	ENST00000296682	T	0.23552	1.9	3.02	1.12	0.20585	Zinc finger, C2H2 (1);Zinc finger, C2H2-type/integrase, DNA-binding (1);	.	.	.	.	T	0.43033	0.1229	M	0.69823	2.125	0.58432	D	0.999997	D	0.89917	1.0	D	0.87578	0.998	T	0.29610	-1.0006	9	0.87932	D	0	-6.4618	5.4205	0.16398	0.1192:0.0:0.6816:0.1992	.	828	Q9NQV7	PRDM9_HUMAN	V	828	ENSP00000296682:G828V	ENSP00000296682:G828V	G	+	2	0	PRDM9	23563437	0.998	0.40836	0.994	0.49952	0.125	0.20455	2.379	0.44318	0.307	0.2288	-0.575	0.04146	GGG	PRDM9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000366375.1	29.056033	KEEP		+	58.534642	0.125581	27	188	---	---	---	---	1	1	45	229	1	251	35	198	0	223	6	TP
GFRAL	389400	broad.mit.edu	37	6	55198595	55198595	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr6:55198595C>A	ENST00000340465.2	+	3	255	c.169C>A	c.(169-171)Ccc>Acc	p.P57T		NM_207410.2	NP_997293.2	Q6UXV0	GFRAL_HUMAN	GDNF family receptor alpha like	57		NA				integral to membrane	receptor activity	p.P57S(1)		NS(1)|breast(1)|endometrium(2)|kidney(5)|large_intestine(2)|liver(1)|lung(31)|ovary(1)|skin(2)|upper_aerodigestive_tract(2)	48	Lung NSC(77;0.0875)|Renal(3;0.122)		LUSC - Lung squamous cell carcinoma(124;0.23)			TCCAGGTGACCCCTGCAAGAT	0.353		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	kidney(1)											131	130	130			NA	NA	6		NA											NA				55198595		2203	4300	6503	SO:0001583	missense			ENSG00000187871	HGNC:32789	NM_207410	Approved	uc003pcm.1	NA	Q5VTF6	ENST00000340465.2	37	CCDS4957.1	.	.	.	.	.	.	.	.	.	.	C	5.278	0.236624	0.10023	.	.	ENSG00000187871	ENST00000340465	T	0.29655	1.56	5.5	-6.19	0.02078	GDNF/GAS1 (1);	0.933586	0.09040	N	0.857491	T	0.02688	0.0081	N	0.08118	0	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.40098	-0.9581	10	0.11182	T	0.66	-14.9491	4.1877	0.10405	0.5953:0.1494:0.1069:0.1484	.	57	Q6UXV0	GFRAL_HUMAN	T	57	ENSP00000343636:P57T	ENSP00000343636:P57T	P	+	1	0	GFRAL	55306554	0	0.05858	0.14	0.22221	0.823	0.46562	-0.548	0.06048	-0.944	0.03686	-0.158	0.13435	CCC	GFRAL-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040995.2	-24.472413	KEEP		+	11.14797	0.03871	6	149	---	---	---	---	1	0.9997213	37	1503	1	1399	7	167	0	258	12	TP
GFRAL	389400	broad.mit.edu	37	6	55198620	55198620	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr6:55198620A>G	ENST00000340465.2	+	3	280	c.194A>G	c.(193-195)tAc>tGc	p.Y65C		NM_207410.2	NP_997293.2	Q6UXV0	GFRAL_HUMAN	GDNF family receptor alpha like	65		NA				integral to membrane	receptor activity			NS(1)|breast(1)|endometrium(2)|kidney(5)|large_intestine(2)|liver(1)|lung(31)|ovary(1)|skin(2)|upper_aerodigestive_tract(2)	48	Lung NSC(77;0.0875)|Renal(3;0.122)		LUSC - Lung squamous cell carcinoma(124;0.23)			AATTCATCATACTGTAACCTG	0.373		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													137	137	137			NA	NA	6		NA											NA				55198620		2203	4300	6503	SO:0001583	missense			ENSG00000187871	HGNC:32789	NM_207410	Approved	uc003pcm.1	NA	Q5VTF6	ENST00000340465.2	37	CCDS4957.1	.	.	.	.	.	.	.	.	.	.	A	7.191	0.591521	0.13812	.	.	ENSG00000187871	ENST00000340465	T	0.29917	1.55	5.39	-7.39	0.01402	GDNF/GAS1 (1);	1.104040	0.06729	N	0.776336	T	0.02304	0.0071	N	0.08118	0	0.09310	N	1	P	0.42123	0.771	B	0.23852	0.049	T	0.31194	-0.9952	10	0.37606	T	0.19	-19.1908	3.0348	0.06118	0.545:0.22:0.1252:0.1098	.	65	Q6UXV0	GFRAL_HUMAN	C	65	ENSP00000343636:Y65C	ENSP00000343636:Y65C	Y	+	2	0	GFRAL	55306579	0	0.05858	0	0.03702	0.372	0.2989	-0.571	0.05889	-1.55	0.01708	0.528	0.53228	TAC	GFRAL-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040995.2	60.872718	KEEP		+	75.824675	0.171233	25	121	---	---	---	---	1	1	405	1138	4	1398	29	141	0	266	12	TP
PPP1R3B	79660	broad.mit.edu	37	8	8998667	8998667	+	Silent	SNP	C	C	T	rs138887555		GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr8:8998667C>T	ENST00000310455.3	-	2	645	c.495G>A	c.(493-495)acG>acA	p.T165T	RP11-10A14.3_ENST00000522057.1_RNA|PPP1R3B_ENST00000519699.1_Silent_p.T165T|RP11-10A14.3_ENST00000520017.1_RNA	NM_001201329.1|NM_024607.3	NP_001188258.1|NP_078883.2	Q86XI6	PPR3B_HUMAN	protein phosphatase 1, regulatory subunit 3B	165	CBM21.	NA			glycogen metabolic process					endometrium(1)|large_intestine(3)|lung(5)|ovary(1)|prostate(1)|skin(1)	12				COAD - Colon adenocarcinoma(149;0.0717)|READ - Rectum adenocarcinoma(644;0.241)		AGGTGTCGAACGTCATCCTTA	0.502		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								C	,	0,4406		0,0,2203	241	204	216		495,495	-11.5	0	8	dbSNP_134	216	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous,coding-synonymous	PPP1R3B	NM_001201329.1,NM_024607.3	,	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	,	165/286,165/286	8998667	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000173281	HGNC:14942	NM_024607	Approved	uc003wsn.4	NA	B3KTV3|Q9H812	ENST00000310455.3	37	CCDS5973.1												NA	NA	NA								NA	NA	NA																																													NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		PPP1R3B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251472.1	103.628623	KEEP		-	125.991071	0.192913	49	205	---	---	---	---	1	1	107	556	1	590	54	238	0	240	16	TP
ARFGAP2	84364	broad.mit.edu	37	11	47196824	47196824	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr11:47196824G>C	ENST00000524782.1	-	4	533	c.305C>G	c.(304-306)gCc>gGc	p.A102G	ARFGAP2_ENST00000319543.6_Intron|ARFGAP2_ENST00000419701.2_Missense_Mutation_p.A23G|ARFGAP2_ENST00000395449.3_5'UTR|ARFGAP2_ENST00000426335.2_Intron	NM_001242832.1|NM_032389.4	NP_001229761.1|NP_115765.2	Q8N6H7	ARFG2_HUMAN	ADP-ribosylation factor GTPase activating protein 2	102	Arf-GAP.|Required for interaction with coatomer.	NA			protein transport|regulation of ARF GTPase activity|vesicle-mediated transport	Golgi membrane|nucleolus|plasma membrane	ARF GTPase activator activity|zinc ion binding			breast(2)|kidney(2)|large_intestine(5)|lung(7)|ovary(3)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	23						TTTGGTGTTGGCATCATTGGC	0.542		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													112	115	114			NA	NA	11		NA											NA				47196824		2201	4298	6499	SO:0001583	missense			ENSG00000149182	HGNC:13504	NM_032389	Approved	uc001ndt.3	NA	D3DQQ9|Q3LIF2|Q8N3I1|Q96SX7	ENST00000524782.1	37	CCDS7926.1	.	.	.	.	.	.	.	.	.	.	G	21.8	4.199748	0.79015	.	.	ENSG00000149182	ENST00000524782;ENST00000419701;ENST00000525398;ENST00000525314;ENST00000528444;ENST00000530596	T;T;T;T;T;T	0.43294	0.95;3.13;0.95;0.95;0.95;0.95	5.52	5.52	0.82312	.	0.059758	0.64402	D	0.000001	T	0.63070	0.2480	M	0.81239	2.535	0.80722	D	1	P;D;P	0.55385	0.811;0.971;0.595	P;P;B	0.55391	0.602;0.775;0.374	T	0.65792	-0.6082	10	0.51188	T	0.08	-16.5353	19.4741	0.94979	0.0:0.0:1.0:0.0	.	102;23;102	B7Z6H9;B4DX29;Q8N6H7	.;.;ARFG2_HUMAN	G	102;23;102;102;102;95	ENSP00000434442:A102G;ENSP00000389264:A23G;ENSP00000431939:A102G;ENSP00000434809:A102G;ENSP00000431684:A102G;ENSP00000435488:A95G	ENSP00000389264:A23G	A	-	2	0	ARFGAP2	47153400	1	0.71417	1	0.80357	0.975	0.68041	9.469	0.97679	2.595	0.87683	0.655	0.94253	GCC	ARFGAP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000391425.1	149.680529	KEEP		-	175.589055	0.199346	61	245	---	---	---	---	1	1	299	1112	0	949	69	298	0	258	2	TP
MS4A1	931	broad.mit.edu	37	11	60233626	60233626	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr11:60233626T>A	ENST00000534668.1	+	5	858	c.569T>A	c.(568-570)tTc>tAc	p.F190Y	MS4A1_ENST00000345732.4_Missense_Mutation_p.F190Y|MS4A1_ENST00000389939.2_Missense_Mutation_p.F190Y|MS4A1_ENST00000532073.1_Missense_Mutation_p.F190Y|MS4A1_ENST00000528313.1_Intron	NM_152866.2	NP_690605.1	P11836	CD20_HUMAN	membrane-spanning 4-domains, subfamily A, member 1	190		NA			B cell activation|immune response	integral to plasma membrane				endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(6)|lung(10)|ovary(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	24					Ibritumomab(DB00078)|Rituximab(DB00073)|Tositumomab(DB00081)	CAATCTCTGTTCTTGGTAAGT	0.418		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													132	124	127			NA	NA	11		NA											NA				60233626		2203	4300	6503	SO:0001583	missense				HGNC:7315		Approved	uc001npq.3	NA	A6NMS4|P08984|Q13963	ENST00000534668.1	37	CCDS31570.1	.	.	.	.	.	.	.	.	.	.	T	11.43	1.636752	0.29068	.	.	ENSG00000156738	ENST00000345732;ENST00000532073;ENST00000534668;ENST00000389939	T;T;T;T	0.02606	4.23;4.23;4.23;4.23	0.137	0.137	0.14787	.	1.231130	0.05521	N	0.562027	T	0.03651	0.0104	L	0.52011	1.625	0.20563	N	0.999882	P;P	0.46784	0.884;0.884	B;B	0.42653	0.394;0.394	T	0.44112	-0.9349	9	0.11485	T	0.65	-6.4921	.	.	.	.	190;190	E9PKH8;P11836	.;CD20_HUMAN	Y	190	ENSP00000314620:F190Y;ENSP00000433519:F190Y;ENSP00000433277:F190Y;ENSP00000374589:F190Y	ENSP00000314620:F190Y	F	+	2	0	MS4A1	59990202	0.772	0.28567	0.468	0.27192	0.074	0.17049	0.309	0.19332	0.249	0.21456	0.246	0.17985	TTC	MS4A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000395402.1	103.088496	KEEP		+	113.492726	0.248619	45	136	---	---	---	---	1	1	81	303	0	291	52	161	0	235	2	TP
HCAR1	27198	broad.mit.edu	37	12	123214503	123214503	+	Silent	SNP	G	G	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr12:123214503G>A	ENST00000432564.1	-	1	626	c.384C>T	c.(382-384)tcC>tcT	p.S128S	HCAR1_ENST00000436083.2_Silent_p.S128S|HCAR1_ENST00000356987.2_Silent_p.S128S	NM_032554.3	NP_115943.1	Q9BXC0	HCAR1_HUMAN	hydroxycarboxylic acid receptor 1	128		NA			response to estradiol stimulus	integral to membrane|plasma membrane	G-protein coupled receptor activity			NS(1)|breast(3)|endometrium(1)|kidney(1)|lung(1)|ovary(1)|pancreas(1)|skin(1)	10						CCACCCGGGTGGAGATAGTGT	0.602		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													56	56	56			NA	NA	12		NA											NA				123214503		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000196917	HGNC:4532		Approved	uc001ucz.3	NA	B2R9X4|Q3Y5J3|Q4VBN1|Q6NXU5	ENST00000432564.1	37	CCDS9236.1												NA	NA	NA								NA	NA	NA																																													NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		HCAR1-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		103.315254	KEEP		-	117.729547	0.218274	43	154	---	---	---	---	1	1	297	1167	2	1254	63	212	0	149	8	TP
RNF17	56163	broad.mit.edu	37	13	25442748	25442748	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr13:25442748C>T	ENST00000255324.5	+	31	4224	c.4172C>T	c.(4171-4173)tCg>tTg	p.S1391L	RNF17_ENST00000339524.3_Missense_Mutation_p.S401L|RNF17_ENST00000381921.1_Missense_Mutation_p.S1349L	NM_001184993.1|NM_031277.2	NP_001171922.1|NP_112567.2	Q9BXT8	RNF17_HUMAN	ring finger protein 17	1391		NA			multicellular organismal development	cytoplasm|nucleus	hydrolase activity, acting on ester bonds|nucleic acid binding|zinc ion binding			NS(1)|breast(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(15)|ovary(1)|prostate(3)|skin(6)	36		Lung SC(185;0.0225)|Breast(139;0.077)		all cancers(112;0.0114)|OV - Ovarian serous cystadenocarcinoma(117;0.0311)|Epithelial(112;0.0524)		GAATTGCTTTCGGCTGAAACA	0.368		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													151	145	147			NA	NA	13		NA											NA				25442748		2203	4300	6503	SO:0001583	missense			ENSG00000132972	HGNC:10060	NM_031994	Approved	uc001upr.3	NA	Q5T2J9|Q6P1W3|Q9BXT7|Q9NUY9	ENST00000255324.5	37	CCDS9308.2	.	.	.	.	.	.	.	.	.	.	C	0.008	-1.891886	0.00522	.	.	ENSG00000132972	ENST00000255324;ENST00000381921;ENST00000418120;ENST00000339524	T;T;T;T	0.24723	3.51;3.54;2.73;1.84	5.93	-2.03	0.07365	.	0.725810	0.11758	N	0.532345	T	0.06234	0.0161	N	0.01219	-0.95	0.09310	N	1	B;B;B;B	0.02656	0.0;0.0;0.0;0.0	B;B;B;B	0.01281	0.0;0.0;0.0;0.0	T	0.34625	-0.9821	10	0.23302	T	0.38	-0.0259	2.3446	0.04268	0.139:0.2508:0.0996:0.5106	.	1387;401;1385;1391	B7Z7S1;Q5T6R1;Q9BXT8-5;Q9BXT8	.;.;.;RNF17_HUMAN	L	1391;1349;715;401	ENSP00000255324:S1391L;ENSP00000371346:S1349L;ENSP00000388892:S715L;ENSP00000344776:S401L	ENSP00000255324:S1391L	S	+	2	0	RNF17	24340748	0	0.05858	0.801	0.32222	0.115	0.19883	-0.552	0.0602	0.025	0.15241	-0.88	0.02959	TCG	RNF17-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000044217.1	72.821375	KEEP		+	86.670592	0.204678	35	136	---	---	---	---	1	1	182	517	3	589	39	157	0	217	10	TP
SERPINA3	12	broad.mit.edu	37	14	95090098	95090098	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr14:95090098G>A	ENST00000553947.1	+	8	2182	c.1294G>A	c.(1294-1296)Gac>Aac	p.D432N	SERPINA3_ENST00000393078.3_Missense_Mutation_p.D407N|SERPINA3_ENST00000482740.1_Missense_Mutation_p.D189N|SERPINA3_ENST00000393080.4_Missense_Mutation_p.D407N|SERPINA3_ENST00000467132.1_Missense_Mutation_p.D407N			P01011	AACT_HUMAN	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3	407		NA			acute-phase response|maintenance of gastrointestinal epithelium|regulation of lipid metabolic process|regulation of proteolysis	extracellular region|nucleus	DNA binding|protein binding|serine-type endopeptidase inhibitor activity	p.D407N(1)		NS(1)|central_nervous_system(2)|endometrium(4)|kidney(3)|large_intestine(6)|lung(17)|ovary(2)|pancreas(1)|skin(3)|stomach(1)	40		all_cancers(154;0.0525)|all_epithelial(191;0.179)		COAD - Colon adenocarcinoma(157;0.212)|Epithelial(152;0.228)		TGTCCCTACAGACACCCAGAA	0.493		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	central_nervous_system(1)											195	170	178			NA	NA	14		NA											NA				95090098		2203	4300	6503	SO:0001583	missense			ENSG00000196136	HGNC:16	NM_001085	Approved	uc001ydp.3	NA	B3KVQ7|Q13703|Q2TU87|Q2TU88|Q59GP9|Q6LBY8|Q6LDT7|Q6NSC9|Q8N177|Q96DW8|Q9UC47|Q9UNU9	ENST00000553947.1	37		.	.	.	.	.	.	.	.	.	.	G	5.98	0.364778	0.11296	.	.	ENSG00000196136	ENST00000553947;ENST00000393078;ENST00000393080;ENST00000467132;ENST00000482740	D;D;D;D;D	0.84223	-1.82;-1.82;-1.82;-1.82;-1.82	4.75	-3.1	0.05315	Serpin domain (3);	1.004250	0.08019	N	0.991636	T	0.74801	0.3764	L	0.49455	1.56	0.09310	N	1	B;B	0.09022	0.0;0.002	B;B	0.08055	0.001;0.003	T	0.57596	-0.7784	10	0.06365	T	0.9	.	7.1608	0.25662	0.3216:0.1168:0.5616:0.0	.	407;432	P01011;G3V5I3	AACT_HUMAN;.	N	432;407;407;407;189	ENSP00000452367:D432N;ENSP00000376793:D407N;ENSP00000376795:D407N;ENSP00000450540:D407N;ENSP00000451119:D189N	ENSP00000376793:D407N	D	+	1	0	SERPINA3	94159851	0	0.05858	0	0.03702	0	0.00434	-2.438	0.01017	-0.497	0.06641	0.563	0.77884	GAC	SERPINA3-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000410738.1	65.930071	KEEP		+	93.672646	0.151261	36	202	---	---	---	---	1	1	339	1090	0	1085	40	236	0	273	2	TP
CCDC33	80125	broad.mit.edu	37	15	74627505	74627505	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr15:74627505G>A	ENST00000268082.4	+	9	1116	c.1096G>A	c.(1096-1098)Ggg>Agg	p.G366R	CCDC33_ENST00000398814.3_Intron|CCDC33_ENST00000321288.5_Intron|CCDC33_ENST00000558821.1_Missense_Mutation_p.G332R			Q8N5R6	CCD33_HUMAN	coiled-coil domain containing 33	0		NA					protein binding			breast(2)|central_nervous_system(2)|endometrium(1)|kidney(2)|large_intestine(2)|lung(17)|ovary(4)|pancreas(1)|skin(5)|upper_aerodigestive_tract(1)|urinary_tract(2)	39						CAAAGTCACTGGGCCCTGAGA	0.587		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													55	60	58			NA	NA	15		NA											NA				74627505		1889	4103	5992	SO:0001583	missense				HGNC:26552	NM_182791	Approved	uc002axo.4	NA	A8K3U4|A8MPQ6|A8MV61|A8MVU9|B3KQ49|Q8TAX6|Q9H5Q6	ENST00000268082.4	37	CCDS42059.1	.	.	.	.	.	.	.	.	.	.	G	15.19	2.761119	0.49468	.	.	ENSG00000140481	ENST00000321374;ENST00000268082	T;T	0.27557	1.66;1.68	4.56	-3.04	0.05412	.	.	.	.	.	T	0.12944	0.0314	.	.	.	0.09310	N	1	B;B	0.13594	0.008;0.008	B;B	0.14023	0.01;0.01	T	0.29397	-1.0013	7	.	.	.	.	1.3432	0.02158	0.2615:0.2616:0.3439:0.1331	.	332;366	Q8N5R6-4;Q8N5R6-5	.;.	R	332;366	ENSP00000325661:G332R;ENSP00000268082:G366R	.	G	+	1	0	CCDC33	72414558	0	0.05858	0	0.03702	0.105	0.19272	0.186	0.16978	-0.406	0.07588	-0.362	0.0751	GGG	CCDC33-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000419494.1	133.409409	KEEP		+	147.532748	0.233945	51	167	---	---	---	---	1	1	258	855	2	1090	57	178	0	145	8	TP
CDH1	999	broad.mit.edu	37	16	68856093	68856093	+	Missense_Mutation	SNP	C	C	T	rs121964878		GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr16:68856093C>T	ENST00000261769.5	+	12	2092	c.1901C>T	c.(1900-1902)gCg>gTg	p.A634V	CDH1_ENST00000562836.1_3'UTR|RP11-354M1.2_ENST00000563916.1_RNA|CDH1_ENST00000422392.2_Missense_Mutation_p.A573V	NM_004360.3	NP_004351.1	P12830	CADH1_HUMAN	cadherin 1, type 1, E-cadherin (epithelial)	634	Cadherin 5.	NA	A -> V (found in a gastric cancer sample; cells exhibited decreased aggregation increased invasiveness and non-uniform migration in vitro compared to cells transfected with wild-type sequence).	ASA -> RVP (in Ref. 3; AAA61259).	adherens junction organization|cellular component disassembly involved in apoptosis|cellular response to indole-3-methanol|cellular response to lithium ion|homophilic cell adhesion|negative regulation of cell-cell adhesion|positive regulation of transcription factor import into nucleus|positive regulation of transcription, DNA-dependent|regulation of immune response	actin cytoskeleton|aggresome|apical junction complex|catenin complex|cell-cell adherens junction|endosome|focal adhesion|Golgi apparatus|integral to membrane|internal side of plasma membrane|lateral plasma membrane|perinuclear region of cytoplasm	cell adhesion molecule binding|gamma-catenin binding	p.A634V(3)		NS(6)|biliary_tract(8)|breast(161)|central_nervous_system(4)|endometrium(9)|kidney(4)|large_intestine(13)|lung(13)|oesophagus(3)|ovary(2)|prostate(3)|soft_tissue(2)|stomach(76)|thyroid(1)|upper_aerodigestive_tract(3)|urinary_tract(3)	311		all_neural(199;0.0189)|Ovarian(137;0.0563)		Epithelial(162;8.44e-05)|all cancers(182;0.000404)|OV - Ovarian serous cystadenocarcinoma(108;0.000426)|BRCA - Breast invasive adenocarcinoma(181;0.0261)		ACACACGGGGCGAGTGCCAAC	0.493		NA	"""Mis, N, F, S"""		"""lobular breast, gastric"""	gastric	NA		Hereditary Diffuse Gastric Cancer					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Familial gastric carcinoma	16	16q22.1	999	"""cadherin 1, type 1, E-cadherin (epithelial) (ECAD)"""	NA	E	3	Substitution - Missense(3)	large_intestine(1)|stomach(1)|central_nervous_system(1)	GRCh37	CM034217	CDH1	M	rs121964878						97	81	86			NA	NA	16		NA											NA				68856093		2198	4300	6498	SO:0001583	missense	Familial Cancer Database	HDGC	ENSG00000039068	HGNC:1748	NM_004360	Approved	uc002ewg.1	NA	Q13799|Q14216|Q15855|Q16194|Q4PJ14	ENST00000261769.5	37	CCDS10869.1	.	.	.	.	.	.	.	.	.	.	C	15.84	2.953019	0.53293	.	.	ENSG00000039068	ENST00000261769;ENST00000379120;ENST00000422392	T;T	0.61274	0.12;0.12	5.68	5.68	0.88126	Cadherin (2);Cadherin-like (1);	0.127123	0.35436	N	0.003216	T	0.49218	0.1544	L	0.49126	1.545	0.29898	N	0.82463	P;B	0.42584	0.784;0.051	B;B	0.37508	0.252;0.007	T	0.56117	-0.8032	10	0.02654	T	1	.	19.4507	0.94865	0.0:1.0:0.0:0.0	.	573;634	Q9UII8;P12830	.;CADH1_HUMAN	V	634;652;573	ENSP00000261769:A634V;ENSP00000414946:A573V	ENSP00000261769:A634V	A	+	2	0	CDH1	67413594	0.952	0.32445	0.991	0.4774	0.89	0.51754	3.125	0.50469	2.697	0.9205	0.632	0.83419	GCG	CDH1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000268897.2	47.89136	KEEP		+	61.50696	0.178571	25	115	---	---	---	---	1	1	201	743	6	792	29	146	0	181	16	TP
TP53	7157	broad.mit.edu	37	17	7577538	7577538	+	Missense_Mutation	SNP	C	C	T	rs11540652		GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr17:7577538C>T	ENST00000420246.2	-	7	875	c.743G>A	c.(742-744)cGg>cAg	p.R248Q	TP53_ENST00000269305.4_Missense_Mutation_p.R248Q|TP53_ENST00000359597.4_Missense_Mutation_p.R248Q|TP53_ENST00000455263.2_Missense_Mutation_p.R248Q|TP53_ENST00000445888.2_Missense_Mutation_p.R248Q|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000413465.2_Missense_Mutation_p.R248Q	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	248	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain.	NA	NR -> IP (in a sporadic cancer; somatic mutation).|NR -> KW (in sporadic cancers; somatic mutation).|R -> C (in a sporadic cancer; somatic mutation).|R -> G (in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs11540652).|R -> W (in LFS; germline mutation and in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.R248Q(580)|p.R248L(75)|p.R248P(19)|p.R155Q(18)|p.0?(8)|p.?(5)|p.R155L(3)|p.R155P(2)|p.N247_R248delNR(2)|p.R248fs*16(2)|p.M246_P250delMNRRP(2)|p.R248_P250delRRP(1)|p.unknown(1)|p.N247_R249delNRR(1)|p.N247_P250delNRRP(1)|p.R249fs*96(1)|p.R248fs*>39(1)|p.R248C(1)|p.G245fs*14(1)|p.N247_R248>IP(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GATGGGCCTCCGGTTCATGCC	0.572	R248Q(BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(CA46_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(DB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(HCC1143_BREAST)|R248Q(HCC70_BREAST)|R248Q(HEC1A_ENDOMETRIUM)|R248Q(HS683_CENTRAL_NERVOUS_SYSTEM)|R248Q(HSC4_UPPER_AERODIGESTIVE_TRACT)|R248Q(KASUMI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KOPN8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KYO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KYSE150_OESOPHAGUS)|R248Q(MOLM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NAMALWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NB4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NCIH211_LUNG)|R248Q(NCIN87_STOMACH)|R248Q(NIHOVCAR3_OVARY)|R248Q(NUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(PANC0203_PANCREAS)|R248Q(PC14_LUNG)|R248Q(PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(RT112_URINARY_TRACT)|R248Q(SEM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(SF295_CENTRAL_NERVOUS_SYSTEM)|R248Q(SKUT1_SOFT_TISSUE)|R248Q(SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(SW1463_LARGE_INTESTINE)|R248Q(WSUDLCL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	725	Substitution - Missense(698)|Whole gene deletion(8)|Deletion - In frame(7)|Unknown(6)|Insertion - Frameshift(3)|Deletion - Frameshift(2)|Complex - compound substitution(1)	large_intestine(138)|breast(83)|haematopoietic_and_lymphoid_tissue(74)|lung(71)|upper_aerodigestive_tract(63)|central_nervous_system(46)|oesophagus(37)|urinary_tract(37)|ovary(36)|stomach(35)|endometrium(23)|skin(18)|prostate(11)|bone(10)|biliary_tract(9)|liver(9)|pancreas(7)|vulva(3)|kidney(3)|cervix(3)|peritoneum(2)|thyroid(2)|soft_tissue(1)|pituitary(1)|adrenal_gland(1)|small_intestine(1)|thymus(1)	GRCh37	CM920675	TP53	M	rs11540652	C	GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG	0,4406		0,0,2203	152	112	126	http://www.ncbi.nlm.nih.gov/sites/varvu?gene	743,743,743,743,347,347,347	3.7	1	17	dbSNP_120	126	1,8599	1.2+/-3.3	0,1,4299	no	missense,missense,missense,missense,missense,missense,missense	TP53	NM_000546.4,NM_001126112.1,NM_001126113.1,NM_001126114.1,NM_001126115.1,NM_001126116.1,NM_001126117.1	43,43,43,43,43,43,43	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging	248/394,248/394,248/347,248/342,116/262,116/210,116/215	7577538	1,13005	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	27.3	4.822907	0.90873	0.0	1.16E-4	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944	D;D;D;D;D;D;D;D	0.99864	-7.28;-7.28;-7.28;-7.28;-7.28;-7.28;-7.28;-7.28	4.62	3.65	0.4185	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99840	0.9927	M	0.88640	2.97	0.58432	A	0.999994	D;D;D;D;D;D	0.89917	1.0;0.994;1.0;1.0;1.0;1.0	D;P;D;D;D;D	0.91635	0.996;0.882;0.999;0.995;0.996;0.995	D	0.96819	0.9602	9	0.72032	D	0.01	-9.5643	10.6687	0.45745	0.0:0.9059:0.0:0.0941	rs11540652;rs11540652	248;248;155;248;248;248	P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;P53_HUMAN;.;.	Q	248;248;248;248;248;248;237;155;116;155	ENSP00000410739:R248Q;ENSP00000352610:R248Q;ENSP00000269305:R248Q;ENSP00000398846:R248Q;ENSP00000391127:R248Q;ENSP00000391478:R248Q;ENSP00000425104:R116Q;ENSP00000423862:R155Q	ENSP00000269305:R248Q	R	-	2	0	TP53	7518263	1	0.71417	1	0.80357	0.887	0.51463	5.884	0.69729	1.305	0.44909	0.462	0.41574	CGG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	45.901585	KEEP		-	57.426972	0.177966	21	97	---	---	---	---	1	1	397	1051	3	1442	23	114	0	88	9	TP
NF1	4763	broad.mit.edu	37	17	29497003	29497003	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr17:29497003C>T	ENST00000358273.4	+	5	957	c.574C>T	c.(574-576)Cga>Tga	p.R192*	NF1_ENST00000431387.4_Nonsense_Mutation_p.R192*|NF1_ENST00000356175.3_Nonsense_Mutation_p.R192*	NM_001042492.2	NP_001035957.1	P21359	NF1_HUMAN	neurofibromin 1	192		NA			actin cytoskeleton organization|adrenal gland development|artery morphogenesis|camera-type eye morphogenesis|cerebral cortex development|collagen fibril organization|forebrain astrocyte development|forebrain morphogenesis|heart development|liver development|MAPKKK cascade|metanephros development|myelination in peripheral nervous system|negative regulation of cell migration|negative regulation of endothelial cell proliferation|negative regulation of MAP kinase activity|negative regulation of MAPKKK cascade|negative regulation of neuroblast proliferation|negative regulation of oligodendrocyte differentiation|negative regulation of transcription factor import into nucleus|osteoblast differentiation|phosphatidylinositol 3-kinase cascade|pigmentation|positive regulation of adenylate cyclase activity|positive regulation of neuron apoptosis|Ras protein signal transduction|regulation of blood vessel endothelial cell migration|regulation of bone resorption|response to hypoxia|smooth muscle tissue development|spinal cord development|sympathetic nervous system development|visual learning|wound healing	axon|cytoplasm|dendrite|intrinsic to internal side of plasma membrane|nucleus	protein binding|Ras GTPase activator activity	p.0?(8)|p.?(4)|p.R192*(2)	NF1/ACCN1(2)	autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9)	599		all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659)		UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146)		AAAATTAAAACGACTCCTGAA	0.284		NA	"""D, Mis, N, F, S, O"""		"""neurofibroma, glioma"""	"""neurofibroma, glioma"""	NA		Neurofibromatosis, type 1	TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Neurofibromatosis type 1	17	17q12	4763	neurofibromatosis type 1 gene	NA	O	14	Whole gene deletion(8)|Unknown(4)|Substitution - Nonsense(2)	soft_tissue(8)|autonomic_ganglia(3)|central_nervous_system(3)	GRCh37	CM000774	NF1	M							73	74	74			NA	NA	17		NA											NA				29497003		2203	4298	6501	SO:0001587	stop_gained	Familial Cancer Database	NF1, von Recklinghausen disease, incl.: Hereditary Spinal Neurofibromatosis, Neurofibromatosis-Noonan syndrome	ENSG00000196712	HGNC:7765	NM_000267	Approved	uc002hgg.3	NA	O00662|Q14284|Q14930|Q9UMK3	ENST00000358273.4	37	CCDS42292.1	.	.	.	.	.	.	.	.	.	.	C	36	5.711613	0.96821	.	.	ENSG00000196712	ENST00000431387;ENST00000358273;ENST00000356175	.	.	.	5.59	3.58	0.4101	.	0.064020	0.64402	D	0.000016	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	9.613	0.39674	0.2526:0.6804:0.0:0.067	.	.	.	.	X	192	.	ENSP00000348498:R192X	R	+	1	2	NF1	26521129	1	0.71417	1	0.80357	0.992	0.81027	2.602	0.46257	0.712	0.32039	0.591	0.81541	CGA	NF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256351.2	19.880991	KEEP		+	27.505422	0.15942	11	58	---	---	---	---	1	0.7159613	3	13	0	6	11	63	0	90	2	TP
CCDC155	147872	broad.mit.edu	37	19	49900952	49900952	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr19:49900952G>T	ENST00000447857.3	+	6	650	c.445G>T	c.(445-447)Ggc>Tgc	p.G149C		NM_144688.4	NP_653289.3	Q8N6L0	CC155_HUMAN	coiled-coil domain containing 155	149		NA				integral to membrane	calcium ion binding			NS(1)|central_nervous_system(1)|endometrium(2)|kidney(4)|large_intestine(2)|lung(10)|ovary(1)|stomach(1)	22						GAGCTTCGGAGGCGAAGACCC	0.622		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													100	116	111			NA	NA	19		NA											NA				49900952		1994	4155	6149	SO:0001583	missense			ENSG00000161609	HGNC:26520	NM_144688	Approved	uc002pnm.2	NA	Q96MC3	ENST00000447857.3	37	CCDS46140.1	.	.	.	.	.	.	.	.	.	.	G	16.87	3.2408	0.58995	.	.	ENSG00000161609	ENST00000447857	T	0.36878	1.23	4.76	4.76	0.60689	.	0.077205	0.49305	D	0.000155	T	0.58793	0.2147	M	0.73598	2.24	0.29370	N	0.864062	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.80764	0.994;0.994;0.971	T	0.58532	-0.7620	10	0.72032	D	0.01	-17.0394	13.447	0.61146	0.0:0.0:1.0:0.0	.	149;149;229	C9JGW3;Q8N6L0;Q6ZRK4	.;CC155_HUMAN;.	C	149	ENSP00000404220:G149C	ENSP00000404220:G149C	G	+	1	0	CCDC155	54592764	1	0.71417	1	0.80357	0.393	0.30537	4.467	0.60155	2.632	0.89209	0.561	0.74099	GGC	CCDC155-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000465436.2	103.18886	KEEP		+	127.229157	0.188679	50	215	---	---	---	---	1	1	445	1093	0	1354	59	243	0	204	2	TP
TMC4	147798	broad.mit.edu	37	19	54667515	54667515	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0210-Tumor-SM-1QUMJ	GBM-TCGA-06-0210-Normal-SM-1QUNQ	g.chr19:54667515C>A	ENST00000376591.4	-	8	1367	c.1236G>T	c.(1234-1236)aaG>aaT	p.K412N	TMC4_ENST00000476013.2_5'Flank|TMC4_ENST00000301187.4_Missense_Mutation_p.K406N|TMC4_ENST00000416963.1_5'Flank	NM_001145303.1|NM_144686.2	NP_001138775.1|NP_653287.1	Q7Z404	TMC4_HUMAN	transmembrane channel-like 4	412		NA				integral to membrane				breast(2)|endometrium(7)|large_intestine(4)|lung(6)|pancreas(1)|skin(1)|urinary_tract(1)	22	all_cancers(19;0.0065)|all_epithelial(19;0.00348)|all_lung(19;0.0175)|Lung NSC(19;0.0325)|Ovarian(34;0.19)					GAGCAATGAGCTTGAACACGG	0.562		NA					NA				OREG0003641	type=REGULATORY REGION|Gene=AK124406|Dataset=Stanford ENCODE Dataset|EvidenceSubtype=Transient transfection luciferase assay		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													106	99	101			NA	NA	19		NA											NA				54667515		2203	4300	6503	SO:0001583	missense			ENSG00000167608	HGNC:22998		Approved	uc010erf.3	1002	Q7Z5M3|Q8N5E4|Q8TBS7	ENST00000376591.4	37	CCDS46174.1	.	.	.	.	.	.	.	.	.	.	C	3.057	-0.194024	0.06259	.	.	ENSG00000167608	ENST00000301187;ENST00000376591	T;T	0.47869	0.83;0.83	5.01	-0.809	0.10864	.	0.736160	0.13737	N	0.366236	T	0.39784	0.1091	L	0.42245	1.32	0.09310	N	0.99999	B;B	0.09022	0.002;0.0	B;B	0.10450	0.001;0.005	T	0.34229	-0.9837	10	0.21014	T	0.42	-1.8059	17.7276	0.88369	0.0:0.4758:0.5242:0.0	.	412;406	Q7Z404;Q7Z404-1	TMC4_HUMAN;.	N	406;412	ENSP00000301187:K406N;ENSP00000365776:K412N	ENSP00000301187:K406N	K	-	3	2	TMC4	59359327	0.051	0.20477	0.906	0.35671	0.057	0.15508	-0.088	0.11198	0.199	0.20427	-0.693	0.03709	AAG	TMC4-011	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000156164.2	83.00351	KEEP		-	100.963717	0.194175	40	166	---	---	---	---	1	1	505	1619	1	1895	45	179	0	173	10	TP
